Search

Search Results
Results 83251 - 83260 of 85911 for ADD
  • Comprehensive analysis of sulfotransferase activity using LC-MS/MS
    Health - 9 Jan 2026
    Explore how LC-MS/MS enables high-throughput phenotyping and inhibition profiling of sulfotransferase enzymes.
  • An Arm and a Leg: A few more good things from 2025
    News - 23 Dec 2025
    An Arm and a Leg host Dan Weissmann breaks down how two states passed laws aimed at protecting people from things like medical debt, insurance delays and denials, and corporate profiteering.
  • NovoSeven RT
    Drug - 19 Dec 2025
    Consumer Medicine Information (CMI) about NovoSeven RT intended for persons living in Australia.
  • NovoThirteen
    Drug - 19 Dec 2025
    Consumer Medicine Information (CMI) about NovoThirteen intended for persons living in Australia.
  • Actilyse
    Drug - 19 Dec 2025
    Consumer Medicine Information (CMI) about Actilyse intended for persons living in Australia.
  • Breo Ellipta
    Drug - 18 Dec 2025
    Consumer Medicine Information (CMI) about Breo Ellipta intended for persons living in Australia.
  • Levemir Penfill
    Drug - 15 Dec 2025
    Consumer Medicine Information (CMI) about Levemir Penfill intended for persons living in Australia.
  • Tenofovir Disoproxil Viatris
    Drug - 15 Dec 2025
    Consumer Medicine Information (CMI) about Tenofovir Disoproxil Viatris intended for persons living in Australia.
  • Simplifying biologic characterization with label-free binding analysis
    Health - 12 Dec 2025
    Learn how label-free quantitation and binding analysis simplify biologic characterization, reducing assay complexity.
  • Levemir FlexPen
    Drug - 12 Dec 2025
    Consumer Medicine Information (CMI) about Levemir FlexPen intended for persons living in Australia.

Terms

While we only use edited and approved content for Azthena answers, it may on occasions provide incorrect responses. Please confirm any data provided with the related suppliers or authors. We do not provide medical advice, if you search for medical information you must always consult a medical professional before acting on any information provided.

Your questions, but not your email details will be shared with OpenAI and retained for 30 days in accordance with their privacy principles.

Please do not ask questions that use sensitive or confidential information.

Read the full Terms & Conditions.

Provide Feedback